Both cases showed neurodegeneration with TDP-43 positive pathology (not identical to but most closely resembling TDP-43 type A), cerebral atrophy while no significant in vivo tracer binding (Supplementary Figs. 4 and 5). This evidence concerns the gene TARDBP and Cerebral atrophy.